Related Experiment Videos
Inoperable recurrence after breast-conserving surgical treatment and radiotherapy
J M Kurtz1, J Jacquemier, H Brandone
1Académie Méditerranéenne d'Oncologie Clinque, Marseille Cancer Institute, France.
Surgery, Gynecology & Obstetrics
|May 1, 1991
Summary
Inoperable breast cancer recurrence after breast-conserving surgery and radiotherapy is rare but serious. Unfavorable prognostic factors predict these difficult-to-treat recurrences, with poor outcomes despite chemotherapy.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Breast-conserving surgery and radiotherapy are standard treatments for early-stage breast cancer.
- Local recurrence remains a concern, and some recurrences are inoperable, posing treatment challenges.
Purpose of the Study:
- To identify factors associated with inoperable local recurrence after breast-conserving operations and megavoltage radiotherapy for Stages I and II breast carcinoma.
- To evaluate the prognosis of patients with inoperable local recurrence.
Main Methods:
- Clinical and pathologic review of 596 patients with Stages I and II breast carcinoma.
- Analysis of local recurrences, focusing on those unsuitable for salvage surgery.
- Median follow-up of 71 months.
Main Results:
- 13 of 70 local recurrences (2.2% of patients) were inoperable.
- Inoperable recurrences occurred in patients with invasive ductal carcinoma and unfavorable prognostic features (positive nodes, grade 3, negative ER, vascular invasion, lymphocytic reaction).
- Prognosis was poor despite doxorubicin-based chemotherapy, though hormone therapy improved survival in receptor-positive, lower-grade tumors.
Conclusions:
- Inoperable local recurrence is a rare but significant complication of breast-conserving treatment for early-stage breast cancer.
- Specific clinicopathologic features predict the risk of inoperable recurrence.
- Treatment strategies, including hormone therapy, may influence outcomes in selected cases.